178 related articles for article (PubMed ID: 32174224)
1. Adolescent ovarian thecoma presenting as progressive hyperandrogenism: case report and review of the literature.
Gaspari L; Paris F; Taourel P; Soyer-Gobillard MO; Kalfa N; Sultan C
Gynecol Endocrinol; 2020 Sep; 36(9):839-842. PubMed ID: 32174224
[TBL] [Abstract][Full Text] [Related]
2. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
[TBL] [Abstract][Full Text] [Related]
3. Virilizing luteinized thecoma of the ovary in a 15-year-old female: a case report.
McGee J; Fleming NA; Senterman M; Black AY
J Pediatr Adolesc Gynecol; 2009 Oct; 22(5):e107-10. PubMed ID: 19576809
[TBL] [Abstract][Full Text] [Related]
4. Ovarian thecoma with androgenic manifestations in a postmenopausal woman.
Siekierska-Hellmann M; Sworczak K; Babińska A; Wojtylak S
Gynecol Endocrinol; 2006 Jul; 22(7):405-8. PubMed ID: 16864153
[TBL] [Abstract][Full Text] [Related]
5. Ovarian thecoma with virilizing manifestations.
Lee MH; Moon YJ; Ha CW; Hoh JK
Yonsei Med J; 2009 Feb; 50(1):169-73. PubMed ID: 19259367
[TBL] [Abstract][Full Text] [Related]
6. Ovarian steroid cell tumor as an example of severe hyperandrogenism in 45-year-old woman.
Szeliga A; Zysnarska A; Podfigurna A; Maciejewska-Jeske M; Moszyński R; Sajdak S; Jasiński P; Frankowski A; Genazzani AR; Męczekalski B
Gynecol Endocrinol; 2020 Apr; 36(4):303-307. PubMed ID: 31718336
[TBL] [Abstract][Full Text] [Related]
7. [Hyperandrogenism in women].
Peigné M; Villers-Capelle A; Robin G; Dewailly D
Presse Med; 2013 Nov; 42(11):1487-99. PubMed ID: 24184282
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal hyperandrogenism: the under-recognized value of inhibins.
Shearer JL; Salmons N; Murphy DJ; Gama R
Ann Clin Biochem; 2017 Jan; 54(1):174-177. PubMed ID: 27278937
[TBL] [Abstract][Full Text] [Related]
9. Androgenetic alopecia in a postmenopausal woman as a result of ovarian hyperthecosis.
Kim Y; Marjoniemi VM; Diamond T; Lim A; Davis G; Murrell D
Australas J Dermatol; 2003 Feb; 44(1):62-6. PubMed ID: 12581085
[TBL] [Abstract][Full Text] [Related]
10. [Virilizing luteoma during pregnancy: biochemical diagnosis and secretory profile of the tumor].
Degrelle H; Habrioux G; Vigneron N; Barrier J
Ann Biol Clin (Paris); 1980; 38(1):16-8. PubMed ID: 6246827
[No Abstract] [Full Text] [Related]
11. [Androgenic alopecia revealing an androgen secreting ovarian tumor].
Roux-Guinot S; Gorin I; Vadrot D; Djid R; Bethoux JP; Escande JP
Ann Dermatol Venereol; 2001 Nov; 128(11):1241-4. PubMed ID: 11908171
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal virilization due to ovarian stromal hyperthecosis.
Braithwaite SS; Erkman-Balis B; Avila TD
J Clin Endocrinol Metab; 1978 Feb; 46(2):295-300. PubMed ID: 220276
[TBL] [Abstract][Full Text] [Related]
13. Combined ovarian vein catheterization with ovarian stimulation in the diagnosis of androgen overproduction.
Cohen I; Cuperman S; Altaras MM; Ben-Nun I; Goldberg E; Beyth Y
Acta Obstet Gynecol Scand; 1992 Apr; 71(3):245-8. PubMed ID: 1317653
[TBL] [Abstract][Full Text] [Related]
14. Ovarian vein sampling in rapidly progressing virilization. A case report.
DeFreitas EA; Dudzinski MR; LaRocque JC; Coddington CC
J Reprod Med; 1991 Jul; 36(7):546-8. PubMed ID: 1941793
[TBL] [Abstract][Full Text] [Related]
15. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
Waggoner W; Boots LR; Azziz R
Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
[TBL] [Abstract][Full Text] [Related]
16. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
Souto SB; Baptista PV; Braga DC; Carvalho D
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
[TBL] [Abstract][Full Text] [Related]
17. Hilus cell tumour of the ovary in a virilized, premenopausal woman. Case report and review of hyperandrogenism of ovarian origin.
Moore A; Permezel M; Mulvany N; Pepperell RJ
Aust N Z J Obstet Gynaecol; 1999 Feb; 39(1):75-8. PubMed ID: 10099755
[TBL] [Abstract][Full Text] [Related]
18. Diffuse stromal Leydig cell hyperplasia: a unique cause of postmenopausal hyperandrogenism and virilization.
Taylor HC; Pillay I; Setrakian S
Mayo Clin Proc; 2000 Mar; 75(3):288-92. PubMed ID: 10725957
[TBL] [Abstract][Full Text] [Related]
19. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
20. Virilizing ovarian tumor of cell tumor type not otherwise specified: a case report.
Faraj G; Di Gregorio S; Misiunas A; Faure EN; Villabrile P; Stringa I; Petroff N; Bur G
Gynecol Endocrinol; 1998 Oct; 12(5):347-52. PubMed ID: 9859028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
